Who backs Cyclarity Therapeutics?
12 investors| Investor | Type |
|---|---|
| National Institutes of Health | Other |
| Formic Ventures | — |
| Starbloom Capital | Family office |
| Ki Tua Fund | Other |
| California Life Sciences | — |
| Chambray Worldwide | — |
| Immortal Dragons | — |
| Kizoo Technology Capital | — |
| Lifespan Extension Advocacy Foundation | — |
| Michael Antonov | — |
| + 2 more investors · a free Private Market View account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Cyclarity Therapeutics investors
12 investors are on record for Cyclarity Therapeutics, including National Institutes of Health, Formic Ventures, Starbloom Capital and Ki Tua Fund. The early-stage round in Dec 2024 drew 19 investors.
Private Market View
More of Cyclarity Therapeutics with a free Private Market View account
- ·The complete investor list: 12 names
- ·Watch Cyclarity Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Cyclarity Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View